| Sorafenib impurity 24/N-Methyl-4-[4-[[2-[(methylamino)carbonyl]-4-pyridinyl]amino]phenoxy]-2-pyridinecarboxamide |
Sorafenib impurity 24/N-Methyl-4-[4-[[2-[(methylamino)carbonyl]-4-pyridinyl]amino]phenoxy]-2-pyridinecarboxamide |
2004659-83-8 |
| Sorafenib impurity 16/Ethyl (4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate |
Sorafenib impurity 16/Ethyl (4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate |
2206827-12-3 |
| Tadalafil iMpurity A |
他达拉非杂质A |
951661-85-1 |
| Fmoc-Arg(Pbf)-Gly-OH |
Fmoc-Arg(Pbf)-Gly-OH |
660846-80-0 |
| Sorafenib related coMpound 8 |
索拉非尼相关物质8 |
1431697-81-2 |
| Oxo Enzalutamide |
恩杂鲁胺杂质J |
1242137-18-3 |
| Apalutamide Desfluoro Impurity |
阿帕他胺去氟杂质 |
1332389-57-7 |
| 3(2H)-Pyridazinone, 6-(4-chlorophenyl)-4,5-dihydro-5-methyl-, (5R)- |
左西孟旦杂质35 |
1630760-90-5 |
| (S)-Allyl 2-((((9H-fluoren-9-yl)Methoxy)carbonyl)aMino)-6-aMinohexanoate hydrochloride |
N2-[芴甲氧羰基]-L-赖氨酸烯丙酯单盐酸盐 |
815619-80-8 |
| L-Lysine, N6-[[[(2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl)sulfonyl]amino]iminomethyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]- |
N-芴甲氧羰基-N'-(2,2,4,6,7-五甲基二氢苯并呋喃-5-磺酰基)-L-高精氨酸 |
1159680-21-3 |
| Regorafenib iMpurity |
瑞戈非尼杂质 |
1333390-56-9 |
| Z-VAL-VAL-OH |
Z-VAL-VAL-OH |
19542-54-2 |
| Z-VAL-PRO-OH |
Z-VAL-PRO-OH |
53331-43-4 |
| Z-VAL-GLY-OET |
Z-VAL-GLY-OET |
2766-17-8 |
| Z-VAL-ALA-OME |
Z-VAL-ALA-OME |
4817-92-9 |
| Z-SAR-OSU |
Z-SAR-OSU;Z-N-METHYLGLYCINE N-HYDROXYSUCCINIMIDE ESTER Z-SARCOSINE N-HYDROXYSUCCINIMIDE ESTER |
53733-96-3 |
| Z-ORN(Z)-OH |
CBZ-ORN(CBZ)-OH |
2274-58-0 |
| Z-PHE-GLY-OH |
Z-PHE-GLY-OH |
13122-99-1 |
| Z-L-LEUCYL-L-ALANINE |
Z-LEU-ALA-OH |
2817-13-2 |
| Z-GLY-GLY-OSU |
Z-GLY-GLY-OSU |
32943-08-1 |
QQ
